Matthew Yim

Matthew Yim

Overview

Matthew is a Counsel in the Hong Kong office of King & Wood Mallesons.

Matthew’s practice covers a broad range of corporate finance transactions including IPOs, public takeovers, mergers and acquisitions, and general corporate and compliance matters. He regularly advises international and domestic clients including investment banks, financial institutions, state-owned enterprises, and multinational corporations in relation to their corporate transactions in Hong Kong, China and Asia.

Matthew received his LL.B. degree from the University of Kent and his LL.M. degree from the University College London.

Matthew is admitted to practice in Hong Kong and is fluent in Cantonese, Mandarin and English.


Recent representative experience:

Equity capital markets

  • Represented Yuexiu Services Group Limited (Stock Code: 6626) on its spin-off listing and HK$1.8 billion Hong Kong IPO on the Main Board of HKEx
  • Represented ABCI Capital Limited as sole sponsor and the underwriters on the HK$760 million Hong Kong IPO of New Hope Service Holdings Limited (Stock Code: 3658) on the Main Board of HKEx
  • Represented Poly Property Development Co, Ltd. (Stock Code: 6049) on its HK$4.68 billion Hong Kong IPO on the Main Board of HKEx
  • Represented Cinda International Capital Limited as sole sponsor and the underwriters on the HK$125 million Hong Kong IPO of Edensoft Holdings Limited (Stock Code: 1147) on the Main Board of HKEx
  • Represented SANVO Fine Chemicals Group Limited (Stock Code: 301) on its HK$130 million Hong Kong IPO on the Main Board of HKEx
  • Represented Ruicheng (China) Media Group Limited (Stock Code: 1640) on its HK$125 million Hong Kong IPO on the Main Board of HKEx
  • Represented Orient Capital (Hong Kong) Limited as sole sponsor and the underwriters on the HK$260 million Hong Kong IPO of Xinyuan Property Management Service (Cayman) Ltd. (Stock Code: 1895) on the Main Board of HKEx
  • Represented RaffAello Capital Limited as sole sponsor and the underwriters on the HK$72.5 million Hong Kong IPO of Dowway Holdings Limited (Stock Code: 8403) on the GEM of HKEx
  • Represented Beijing Beida Jade Bird Universal Sci-Tech Company Limited (Stock Code: 8095) on the spin-off and RMB1.04 billion listing of Jade Bird Fire Co., Ltd. on the SME Board of the Shenzhen Stock Exchange
  • Represented China Everbright Capital Limited as sole sponsor and the underwriters on the HK$672 million Hong Kong IPO of Xinming China Holdings Limited (Stock Code: 2699) on the Main Board of HKEx
  • Represented Medicskin Holdings Limited (Stock Code: 8307) on its HK$60 million Hong Kong IPO on the GEM of HKEx


Mergers and Acquisitions

  • Represented Livzon Pharmaceutical Group Inc. (Stock Code: 1513) on its RMB724 million acquisition of 40% equity interest in Tianjin Tongrentang Group Co., Ltd.
  • Represented an Australian listed company on its proposed acquisition of a Hong Kong incorporated company which is principally engaged in corporate and financial management services
  • Represented GF Capital (Hong Kong) Limited as financial adviser to Gentle Soar Limited on its HK$469 million acquisition of 70% of the issued shares of FDB Holdings Limited (Stock Code: 1826) and its subsequent mandatory unconditional general offer under the Hong Kong Takeovers Code
  • Represented Huarong International Capital Limited and Goldin Financial Limited as joint financial advisers to State Energy HK Limited on its HK$648 million acquisition of 75% of the issued shares of LC Group Holdings Limited (Stock Code: 1683) and its subsequent mandatory unconditional general offer under the Hong Kong Takeovers Code
  • Represented Huarong International Capital Limited and Goldin Financial Limited as joint financial advisers to State Energy HK Limited on its HK$487 million acquisition of 66.4% of the issued shares of Takson Holdings Limited (Stock Code: 918) and its subsequent mandatory unconditional general offer under the Hong Kong Takeovers Code
  • Represented Gold-Finance (Hong Kong) Asset Management Limited on its HK$735 million acquisition of 75% of the issued shares of Nga Chun Holdings Company Limited (Stock Code: 1462) and its subsequent mandatory unconditional general offer under the Hong Kong Takeovers Code
  • Represented International Elite Ltd. (Stock Code: 1328) on its conditional subscription of new shares of Global Link Communications Holdings Limited (Stock Code: 8060) through its wholly-owned subsidiary and its subsequent mandatory unconditional general offer under the Hong Kong Takeovers Code
  • Represented a U.S. based securities trading company on its 100% acquisition of a Hong Kong incorporated company which is a licensed corporation under the SFO


Compliance and others

  • Represented Guangdong Join-Share Financing Guarantee Investment Co., Ltd. (Stock Code: 1543) on its discloseable and connected transactions in relation to disposal of the equity interest in Guangdong Yaoda Financial Leasing Company Limited
  • Represented a BVI joint venture company on its private placement of shares for the purpose of funding a residential property development in Hong Kong
  • Represented a private equity firm on the private placement of shares of a Hong Kong incorporated company established for the purpose of developing and distributing medical device technology in the PRC
  • Represented a U.S. based brokerage firm on the licensing requirements under the SFO for carrying out the regulated activities in Hong Kong
  • Represented various listed companies including Livzon Pharmaceutical Group Inc. (Stock Code: 1513), Guangdong Join-Share Financing Guarantee Investment Co., Ltd. (Stock Code: 1543), Edensoft Holdings Limited (Stock Code: 1147), SANVO Fine Chemicals Group Limited (Stock Code: 301), Ruicheng (China) Media Group Limited (Stock Code: 1640), Universal Star (Holdings) Limited (Stock Code: 2346), China Lesso Group Holdings Limited (Stock Code: 2128) and Shandong Xinhua Pharmaceutical Company Limited (Stock Code: 719) in relation to their compliance matters under the Hong Kong Listing Rules

Location

This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

For more information on which cookies we use then please refer to our Cookie Policy.